Market Outlook

By 2035, the U.S. Infection Prevention Equipment Market is expected to reach approximately USD 15.84 billion, expanding at a CAGR of 7.90% during the forecast period 2026–2035. The market was valued at approximately USD 7.40 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

The market scope includes sterilization systems, washer-disinfectors, automated endoscope reprocessors, low-temperature sterilization platforms, room and surface decontamination equipment, ultraviolet disinfection systems, air and water infection-control equipment, sterilization monitoring products, traceability platforms, and equipment-linked accessories and service contracts. General-purpose personal protective equipment and stand-alone commodity disinfectant chemicals are excluded unless they form an integrated component of an infection-prevention equipment platform.

The U.S. infection prevention equipment industry is becoming a strategically important component of hospital quality, surgical capacity, medical device safety, pharmaceutical manufacturing, and healthcare workforce protection. Demand is supported by the continued incidence of healthcare-associated infections, the increasing complexity of reusable medical devices, growth in surgical and endoscopic procedures, expansion of outpatient care, and stronger regulatory scrutiny of sterilization and disinfection processes.

An estimated 518,000 healthcare-associated infections occurred in U.S. acute care hospitals in 2023. Approximately 2.6% of hospitalized patients had at least one healthcare-associated infection, equivalent to about one in every 38 patients on any given day. Although national infection rates have improved substantially over the last decade, the remaining clinical burden is large enough to sustain investment in automated cleaning, sterilization, environmental decontamination, infection surveillance, and reprocessing quality assurance.

The historical market expanded from approximately USD 5.26 billion in 2021 to USD 6.72 billion in 2024. Growth during this period was supported by the restoration of elective procedures after the pandemic, modernization of central sterile processing departments, replacement of aging steam sterilizers and washer-disinfectors, increased demand for low-temperature sterilization, and greater adoption of automated endoscope reprocessing systems.

In 2025, the market reached approximately USD 7.40 billion as health systems accelerated capital spending on sterile processing capacity, digital instrument tracking, high-level disinfection automation, ultraviolet room decontamination, water-quality management, and infection-control infrastructure for ambulatory facilities. The U.S. had approximately 6,100 hospitals, more than 907,000 staffed hospital beds, and over 35.6 million annual hospital admissions, illustrating the scale of the installed healthcare infrastructure requiring recurring infection-prevention equipment, validation, maintenance, and consumables.

The market’s growth trajectory through 2035 will not be based solely on the purchase of additional sterilizers or disinfection units. Value creation will increasingly come from connected equipment ecosystems that improve reprocessing reliability, document compliance, reduce instrument turnaround time, predict maintenance requirements, and provide infection-prevention teams with auditable process data.

Hospitals are shifting from equipment-by-equipment procurement toward enterprise infection-prevention strategies. Buyers increasingly want integrated solutions covering instrument receipt, cleaning, inspection, assembly, sterilization, storage, transport, procedural use, and post-use return. Manufacturers capable of connecting physical equipment with workflow software, biological and chemical monitoring, remote service, staff training, and compliance documentation will be positioned to capture a larger share of hospital capital budgets.

 

Introduction

According to the U.S. Infection Prevention Equipment Market Report, the industry is shaped by a combination of persistent infection risk, large procedural volumes, advanced healthcare infrastructure, strict quality requirements, and an extensive installed base of reusable medical equipment. Infection prevention equipment is essential across hospitals, ambulatory surgery centers, gastrointestinal clinics, dental practices, pharmaceutical plants, medical device manufacturing facilities, laboratories, long-term care facilities, and specialty treatment centers.

The market includes both capital-intensive and recurring-revenue categories. Steam sterilizers, low-temperature sterilizers, washer-disinfectors, cart washers, automated endoscope reprocessors, ultraviolet disinfection robots, and water treatment systems represent major capital purchases. Biological indicators, chemical indicators, sterilization packaging, monitoring systems, replacement components, detergents, filters, service contracts, software subscriptions, and validation services create recurring revenue throughout the equipment lifecycle.

This combination gives the market a balanced commercial profile. Equipment replacement cycles provide a predictable baseline of demand, while regulatory changes, procedural migration, infection outbreaks, facility expansion, and technological innovation create incremental growth opportunities. Large health systems generally replace sterilization and disinfection equipment through multi-year capital plans, whereas ambulatory facilities and specialty clinics tend to make smaller, procedure-driven purchasing decisions.

The clinical importance of infection prevention extends beyond reported hospital infection rates. Reusable surgical instruments and flexible endoscopes can contain narrow channels, joints, hinges, valves, insulation, polymer components, and heat-sensitive materials that complicate cleaning and sterilization. The growing technical sophistication of minimally invasive instruments increases the importance of validated cleaning, drying, inspection, traceability, and sterilization processes.

The market is also closely linked to the economics of U.S. healthcare delivery. Hospital expenditures reached approximately USD 1.63 trillion in 2024. Preventable infections can extend length of stay, require additional antibiotic therapy, increase laboratory and imaging utilization, delay discharge, create readmissions, and expose providers to reimbursement penalties or litigation. Infection-prevention equipment therefore competes for capital not only as a compliance requirement but also as a tool for protecting clinical capacity and avoiding preventable costs.

Procurement decisions are becoming increasingly cross-functional. Infection prevention leaders assess clinical risk and outbreak-prevention value. Sterile processing departments evaluate throughput, ergonomics, chamber capacity, instrument compatibility, and workflow. Biomedical engineering teams consider serviceability and uptime. Information technology departments review cybersecurity and system integration. Finance teams examine lifecycle cost, while sustainability leaders assess water, energy, chemical, packaging, and waste implications.

From 2026 to 2035, the most important market transition will be the movement from manually documented infection-prevention processes toward digitally verified workflows. Equipment that automatically captures cycle parameters, instrument identity, operator actions, maintenance status, quality-control results, and load release decisions will gain preference over isolated machines with limited data integration.

 

Key Market Drivers: What’s Fueling the U.S. Infection Prevention Equipment Market Boom?

The primary market driver is the continuing burden of healthcare-associated infections. U.S. hospitals reported meaningful reductions in several major infection categories during 2024, including decreases in central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated events, hospital-onset methicillin-resistant Staphylococcus aureus bacteremia, and hospital-onset Clostridioides difficile infections. These improvements demonstrate that prevention programs can produce measurable results, but they also reinforce the need for sustained investment rather than reduced attention.

Healthcare facilities cannot depend on behavioral compliance alone. Reliable infection prevention requires equipment-supported processes that are standardized, repeatable, validated, and documented. Automated washer-disinfectors, sterilizers, endoscope reprocessors, environmental disinfection systems, monitoring platforms, and instrument-tracking solutions reduce variation and help facilities demonstrate that required procedures were completed.

A second major driver is the expansion and increasing complexity of surgical care. Hospitals are performing more minimally invasive, robotic, orthopedic, cardiovascular, ophthalmic, neurosurgical, and endoscopic procedures that depend on specialized reusable instruments. These devices are frequently expensive and available in limited quantities, making reprocessing speed and reliability operationally critical.

When sterile processing throughput is inadequate, operating room schedules can be delayed even when surgical staff and procedure rooms are available. Hospitals are therefore investing in higher-capacity sterilizers, faster low-temperature cycles, automated transport systems, improved drying technology, instrument inspection systems, and workflow software to increase asset utilization without compromising safety.

A third driver is the growth of ambulatory surgery centers and office-based procedural care. The number of Medicare-certified ambulatory surgery centers increased to approximately 6,436 in 2024. These facilities are performing a broader range of orthopedic, ophthalmic, pain-management, gastrointestinal, cardiovascular, urologic, and general surgical procedures.

Ambulatory facilities require infection-prevention equipment that fits smaller physical footprints, lower staffing levels, rapid patient turnover, and tighter reimbursement economics. Compact steam sterilizers, tabletop units, small-capacity washer-disinfectors, automated endoscope reprocessors, instrument-tracking software, and simplified quality-control systems are therefore gaining relevance outside traditional hospitals.

A fourth driver is heightened scrutiny of endoscope reprocessing. Flexible endoscopes are difficult to clean because of their long internal channels, narrow lumens, valves, elevators, and heat-sensitive components. Reprocessing involves multiple steps, including pre-cleaning, leak testing, manual cleaning, rinsing, high-level disinfection or sterilization, drying, storage, and transport.

Failures at any stage can create contamination risk. Hospitals and gastrointestinal facilities are consequently increasing investment in automated endoscope reprocessors, drying cabinets, channel-drying systems, leak testers, borescopes, water-quality monitoring, transport containers, and digital documentation. The replacement of older endoscopes with disposable-component or single-use designs will alter some reprocessing demand, but the large installed base of reusable flexible endoscopes will sustain equipment requirements through the forecast period.

A fifth driver is the regulatory transition affecting ethylene oxide sterilization. Approximately half of sterile medical devices used in the United States are sterilized with ethylene oxide, including many products that cannot tolerate heat, moisture, radiation, or alternative chemical processes. Environmental and occupational concerns surrounding ethylene oxide emissions have increased pressure on sterilization facilities to install emission-control technology, improve monitoring, optimize cycle efficiency, and evaluate alternative methods.

This transition supports investment in vaporized hydrogen peroxide, electron-beam processing, nitrogen dioxide, chlorine dioxide, vaporized peracetic acid, and other emerging sterilization technologies. Ethylene oxide will remain strategically important, but manufacturers and healthcare systems are seeking diversified sterilization capacity to reduce regulatory, environmental, and supply-chain risk.

A sixth driver is the FDA’s recognition of vaporized hydrogen peroxide as an established medical device sterilization method. This regulatory recognition reduces uncertainty for device manufacturers seeking to qualify vaporized hydrogen peroxide as an alternative to ethylene oxide or other low-temperature processes. It also creates opportunities for equipment suppliers, validation specialists, packaging companies, biological indicator manufacturers, and contract sterilization providers.

A seventh driver is the increasing importance of hospital quality economics. Healthcare-associated infections can affect publicly reported quality measures, payer negotiations, patient satisfaction, accreditation outcomes, legal exposure, and hospital reputation. Capital requests for infection-prevention equipment are therefore increasingly supported by risk-adjusted business cases.

Hospitals are evaluating whether equipment can reduce rejected loads, prevent wet packs, decrease instrument damage, shorten reprocessing cycles, lower water consumption, improve staff productivity, and protect operating room revenue. Suppliers that quantify these operational benefits can compete more effectively than vendors relying primarily on technical product specifications.

An eighth driver is the national shortage of experienced sterile processing personnel. Sterile processing departments operate under demanding conditions involving high workloads, detailed instructions for use, manual inspection requirements, and strict documentation. Staffing shortages increase the value of equipment that automates repetitive work, provides guided workflows, detects process deviations, and reduces dependence on institutional knowledge.

Ergonomic loading systems, automatic dosing, barcode scanning, digital work instructions, instrument recognition, remote technical support, and predictive maintenance can improve productivity while reducing operator burden. Automation will not eliminate the need for trained personnel, but it can help facilities allocate skilled employees toward inspection, quality assurance, and complex instrument management.

A ninth driver is the continued expansion of pharmaceutical, biotechnology, and medical device manufacturing. These industries require sterilization, cleanroom decontamination, component washing, contamination-control monitoring, and validated production environments. Growth in biologics, cell and gene therapies, combination products, implantable devices, and sterile injectables creates demand for specialized sterilization and disinfection equipment outside conventional healthcare facilities.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. infection prevention equipment market is focused on process verification, low-temperature compatibility, workflow automation, sustainability, and data integration. The competitive standard is moving beyond whether equipment can complete a sterilization or disinfection cycle. Hospitals now expect systems to demonstrate that the correct device was processed through the correct validated workflow by an authorized operator using acceptable cycle parameters.

Digitally connected sterile processing departments represent one of the most important areas of innovation. Modern tracking systems can follow instruments from the operating room to decontamination, assembly, sterilization, storage, and return to clinical use. Barcode and radio-frequency identification technologies help facilities locate trays, document reprocessing histories, monitor repair frequency, identify missing instruments, and analyze utilization.

When integrated with operating room scheduling, instrument-tracking platforms can help sterile processing teams prioritize urgent trays and reduce unnecessary processing. Manufacturers are adding analytics that identify bottlenecks, predict demand, measure turnaround time, monitor load failures, and support productivity benchmarking across multiple hospital sites.

Low-temperature sterilization is another major innovation area. Robotic instruments, powered devices, cameras, flexible components, electronics, and complex polymers may not tolerate repeated steam sterilization. Vaporized hydrogen peroxide systems are gaining adoption because of their relatively short cycles, low-temperature operation, and absence of toxic residuals associated with some alternative processes.

Future competition will focus on chamber capacity, cycle flexibility, instrument compatibility, lumen capability, packaging requirements, consumable cost, and validated claims. Hospitals are particularly interested in systems capable of processing a broader range of devices without forcing departments to maintain multiple specialized sterilization platforms.

Endoscope reprocessing innovation is increasingly centered on drying and traceability. Automated endoscope reprocessors standardize high-level disinfection, but effective cleaning before disinfection and complete drying afterward remain essential. New systems combine automated channel flushing, alcohol purging, forced-air drying, storage monitoring, scope identification, operator identification, and cycle documentation.

Borescope inspection is also gaining attention because it allows technicians to view internal channels that cannot be assessed through external visual inspection. The combination of automated reprocessing, channel inspection, drying verification, and electronic recordkeeping is creating a more comprehensive quality-control model for flexible endoscopes.

No-touch environmental disinfection is evolving beyond pandemic-driven demand. Ultraviolet-C systems and vaporized hydrogen peroxide room-decontamination platforms are being positioned for terminal cleaning of high-risk rooms, operating rooms, isolation rooms, intensive care units, burn units, and areas associated with multidrug-resistant organisms.

The value proposition is shifting toward workflow integration. Hospitals want systems that automatically calculate treatment time, verify room geometry, document completed cycles, restrict access during operation, and transfer records to infection-prevention dashboards. Autonomous navigation and improved sensor technology may increase adoption in facilities where manual positioning previously limited utilization.

Artificial intelligence and computer vision are beginning to influence infection-prevention workflows. Potential applications include identifying surgical instruments during assembly, verifying tray completeness, detecting visible soil or damage, monitoring hand-hygiene events, assessing environmental cleaning coverage, and prioritizing maintenance. Adoption will depend on validation, workflow reliability, data governance, cybersecurity, and the ability to generate measurable labor or quality improvements.

Sustainability is becoming a more important equipment-design consideration. Sterile processing departments are significant users of water, steam, electricity, detergents, packaging, and compressed air. Hospitals are seeking equipment that reduces utility consumption without weakening cycle efficacy. Heat recovery, intelligent load sensing, optimized rinse cycles, reduced chemical dosing, reusable rigid containers, and energy-efficient drying systems can improve operating economics while supporting environmental targets.

Manufacturers are also expanding remote service and predictive maintenance. Infection-prevention equipment is mission-critical, and unexpected downtime can disrupt procedural schedules. Connected systems can monitor pumps, valves, temperature sensors, pressure, door seals, chemical levels, and cycle performance. Remote diagnostics allow service organizations to identify failures earlier, reduce emergency visits, and improve parts availability.

The strongest product platforms will combine physical equipment, validation, monitoring, software, service, training, and workflow redesign. Hospitals are increasingly reluctant to purchase complex technology without implementation support. Manufacturers that can assess a facility’s instrument volume, space constraints, staffing, water quality, transport routes, and projected procedure growth will be better positioned to win enterprise contracts.

 

Segmentation Insights

The U.S. Infection Prevention Equipment Market is segmented on the basis of product type, technology, application, end user, and region.

 

By Product Type

Sterilization Equipment

Sterilization equipment represents the largest product category, accounting for an estimated USD 2.31 billion in 2025. The segment includes steam sterilizers, dry-heat sterilizers, ethylene oxide systems, vaporized hydrogen peroxide sterilizers, radiation-based equipment, and other low-temperature technologies.

Steam sterilizers provide the largest installed base because they are effective, familiar, and economically efficient for heat- and moisture-tolerant instruments. Demand is supported by equipment replacement, hospital renovation, new surgical facilities, and the need for higher chamber capacity.

Low-temperature sterilizers are expected to grow faster than conventional steam systems. Increasing use of heat-sensitive robotic, endoscopic, electronic, and polymer-based devices is expanding the addressable market. Procurement decisions are influenced by device compatibility, cycle speed, chamber size, consumable cost, environmental requirements, and the number of instruments validated for each system.

Washer-Disinfectors and Cart Washers

Washer-disinfectors and cart washers form a critical part of automated decontamination. The segment includes single-chamber and multi-chamber washer-disinfectors, tunnel washers, ultrasonic cleaning systems, cart washers, and equipment used for containers, utensils, and patient-care items.

Hospitals are adopting automated systems to reduce manual cleaning variability and protect employees from sharps, chemicals, contaminated fluids, and repetitive physical work. Multi-chamber systems are attractive to high-volume academic centers and large integrated delivery networks, while compact systems are better suited to community hospitals, dental facilities, outpatient centers, and satellite clinics.

Endoscope Reprocessing Equipment

Endoscope reprocessing equipment generated an estimated USD 1.15 billion in 2025. The segment includes automated endoscope reprocessors, leak testers, endoscope drying cabinets, transport systems, storage systems, water treatment equipment, channel-drying systems, cleaning verification products, and borescope inspection devices.

Demand is supported by large gastrointestinal procedure volumes and the clinical importance of reliable reprocessing. Facilities are moving toward integrated reprocessing rooms designed around one-way workflow, controlled storage, improved ventilation, and electronic documentation. Automated endoscope reprocessors with dual-basin capacity, faster cycles, improved connectivity, and broad scope compatibility will gain preference among high-volume users.

Environmental Disinfection and Room-Decontamination Equipment

This segment includes ultraviolet-C devices, vaporized hydrogen peroxide systems, aerosolized disinfectant systems, electrostatic application equipment, air disinfection systems, and mobile room-decontamination platforms. It accounted for an estimated USD 0.95 billion in 2025.

Demand accelerated during the pandemic but is transitioning toward a more selective, evidence-based purchasing environment. Hospitals are prioritizing high-risk applications rather than facility-wide deployment. Adoption is strongest where systems can be integrated into terminal cleaning without delaying room availability.

Sterilization Monitoring, Traceability and Accessories

Monitoring and traceability products include biological indicators, chemical indicators, incubators, process challenge devices, load documentation systems, instrument-tracking software, sterilization packaging, rigid containers, labels, scanners, and quality-control accessories.

The segment benefits from recurring demand because indicators and packaging materials are consumed with each load or procedure. Digital traceability is creating additional software and service revenue. Hospitals increasingly require the ability to connect individual instruments or trays to sterilizer cycles, patients, procedures, operators, and quality-control outcomes.

 

By Technology

Steam and Thermal Sterilization

Steam sterilization remains the dominant technology because of its broad clinical acceptance, high microbial efficacy, relatively low operating cost, and suitability for stainless-steel surgical instruments. Hospitals rely on gravity and pre-vacuum sterilizers for routine instrument processing.

Growth is primarily replacement-driven, but demand remains stable because surgical volumes continue to increase. Innovation is focused on shorter cycles, improved drying, intelligent load management, utility efficiency, automatic documentation, and integration with instrument-tracking systems.

Low-Temperature Chemical and Gas Sterilization

Low-temperature technologies include vaporized hydrogen peroxide, ethylene oxide, nitrogen dioxide, chlorine dioxide, ozone, and other chemical processes. This technology segment is expected to record one of the highest growth rates through 2035.

Vaporized hydrogen peroxide is gaining momentum within hospitals, while ethylene oxide remains essential for industrial sterilization of complex and heat-sensitive medical products. The long-term technology mix will be shaped by regulatory policy, material compatibility, device labeling, emissions control, cycle duration, sterilization capacity, and supply-chain requirements.

Automated Cleaning and High-Level Disinfection

Automated cleaning and high-level disinfection technologies include washer-disinfectors, automated endoscope reprocessors, ultrasonic cleaners, chemical dosing systems, and automated flushing platforms. These technologies improve process consistency and reduce dependence on manual steps.

The segment is particularly important for endoscopy, respiratory care, anesthesia equipment, surgical instruments, and reusable patient-care items. Manufacturers are differentiating systems through sensor accuracy, chemical management, cycle documentation, water-quality controls, and connectivity.

Ultraviolet and No-Touch Decontamination

Ultraviolet-C, pulsed ultraviolet, vaporized hydrogen peroxide, and other no-touch technologies are used to supplement manual environmental cleaning. These systems are being refined to reduce cycle time and improve coverage.

Adoption is expected to remain concentrated in larger hospitals, high-risk specialty units, and facilities with established environmental services teams. Buyers will increasingly demand evidence of utilization, not merely equipment availability, making workflow software and automated cycle records important differentiators.

Digital, Sensor-Based and Connected Technologies

Digital technologies include instrument tracking, cycle monitoring, automated documentation, environmental sensors, water-quality monitoring, hand-hygiene monitoring, computer vision, remote service, and predictive maintenance.

Although this category represents a smaller share of market revenue than sterilizers and washer-disinfectors, it is expected to influence purchasing decisions across all product segments. Digital capability can extend the commercial life of equipment platforms by generating software, analytics, training, and service revenue.

 

By Application

Surgical Instrument Reprocessing

Surgical instrument reprocessing is the largest application segment, representing approximately USD 2.35 billion in 2025. It covers cleaning, disinfection, inspection, assembly, sterilization, storage, and transport of reusable surgical devices.

Growth is supported by increasing procedure volumes, robotic surgery, minimally invasive surgery, and the rising cost of specialized instrument sets. Hospitals are investing in reprocessing capacity because instrument availability directly influences operating room productivity.

Endoscope Reprocessing

Endoscope reprocessing is among the fastest-growing applications because flexible endoscopes require complex, device-specific workflows. The segment includes gastrointestinal, pulmonary, urologic, otolaryngology, and surgical endoscopes.

Demand is shifting toward fully documented reprocessing environments with automated leak testing, cleaning verification, high-level disinfection, forced-air drying, secure storage, and scope tracking. Facilities with aging reprocessing rooms are expected to undertake significant modernization during the forecast period.

Environmental and Surface Decontamination

Environmental decontamination includes operating rooms, patient rooms, intensive care units, isolation areas, emergency departments, laboratories, and ambulatory procedure rooms. Equipment is used to supplement manual cleaning and reduce environmental reservoirs of pathogens.

This application requires careful workflow management because room-treatment time can affect bed turnover and operating room utilization. Faster systems with automated reporting will be better positioned for routine use.

Medical Device and Pharmaceutical Manufacturing

Manufacturers use sterilization and contamination-control equipment for medical devices, sterile pharmaceuticals, biologics, packaging components, production environments, and laboratory materials. This segment includes industrial ethylene oxide, radiation, vaporized hydrogen peroxide, steam, dry heat, and cleanroom decontamination systems.

Growth is supported by domestic manufacturing initiatives, biologic drug production, sterile injectable capacity expansion, and increased regulatory attention to contamination control. Industrial customers place strong emphasis on validation, process reproducibility, throughput, emissions compliance, and supply continuity.

Air, Water and Facility Infection Control

Air and water infection control includes high-efficiency particulate air filtration, ultraviolet air treatment, ventilation-support equipment, water filtration, reverse osmosis, microbial monitoring, and systems used to reduce contamination in sterile processing and clinical areas.

Water quality is particularly important for final rinsing, steam generation, endoscope reprocessing, and protection of equipment from scale or corrosion. As reusable medical devices become more complex, water-treatment performance will receive greater attention from facility planners and sterile processing leaders.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated health systems are the dominant end users, representing approximately USD 3.72 billion in 2025. They purchase the largest sterilizers, multi-chamber washer-disinfectors, cart washers, automated endoscope reprocessors, room-decontamination systems, instrument-tracking platforms, and enterprise service contracts.

Large systems are increasingly standardizing equipment across multiple hospitals to improve training, service efficiency, purchasing leverage, and data comparability. Enterprise contracts create opportunities for manufacturers with broad portfolios and nationwide service capabilities.

Ambulatory Surgery Centers and Specialty Clinics

Ambulatory surgery centers and specialty clinics represent a fast-growing end-user segment. Gastrointestinal, ophthalmic, orthopedic, dental, urologic, pain-management, and office-based procedural facilities require compact equipment and simplified workflows.

These buyers are highly sensitive to space, labor, cycle time, and operating cost. Vendors that offer right-sized equipment, financing, remote support, and bundled consumables are likely to gain share.

Pharmaceutical and Medical Device Manufacturers

Pharmaceutical and medical device manufacturers require industrial-scale sterilization, cleanroom decontamination, component washing, process monitoring, and validation. Their purchasing decisions involve quality assurance, engineering, environmental health and safety, regulatory affairs, and supply-chain teams.

The segment offers high contract values but long sales cycles. Equipment qualification, installation, validation, emissions controls, and production integration can take several years, creating substantial barriers to switching suppliers.

Long-Term Care, Dental and Other Outpatient Facilities

The United States has more than 15,000 Medicare- and Medicaid-certified nursing homes and approximately 1.2 million residents in certified long-term care facilities. Infection prevention in these settings is receiving greater attention because residents are often older, medically complex, and vulnerable to respiratory, gastrointestinal, skin, urinary, and multidrug-resistant infections.

Dental practices, dialysis centers, physician offices, laboratories, and other outpatient facilities also require tabletop sterilizers, ultrasonic cleaners, water-treatment products, surface-decontamination equipment, and monitoring supplies. The market is fragmented, favoring distributors and manufacturers with strong channel coverage.

Contract Sterilization and Reprocessing Service Providers

Contract sterilization and outsourced reprocessing providers serve medical device companies, hospitals, and healthcare networks that lack sufficient internal capacity. Services include ethylene oxide sterilization, radiation sterilization, instrument repair, off-site sterile processing, and mobile reprocessing support.

This segment is gaining strategic importance as facilities seek additional capacity and supply-chain resilience. However, outsourced models require validated transport, chain-of-custody controls, inventory planning, and rapid turnaround.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Infection Prevention Equipment Market is geographically segmented into the Northeast, Midwest, South, and West. Regional performance differs according to population, hospital density, procedure volumes, manufacturing concentration, healthcare construction, disease burden, regulatory intensity, ambulatory surgery penetration, and the age of installed sterilization infrastructure.

The South represented the largest regional market in 2025, while the West is projected to record the fastest growth through 2035. The Northeast remains the most academically and clinically sophisticated market, while the Midwest offers a stable combination of hospital, medical device manufacturing, pharmaceutical, and contract sterilization demand.

South

The South accounted for an estimated USD 2.66 billion in 2025 and is projected to reach approximately USD 5.81 billion by 2035, representing an estimated regional CAGR of 8.13%. The region includes Texas, Florida, Georgia, North Carolina, South Carolina, Virginia, West Virginia, Maryland, Delaware, Tennessee, Kentucky, Alabama, Mississippi, Louisiana, Arkansas and Oklahoma.

Regional leadership is supported by large population centers, rapid healthcare construction, high inpatient and outpatient volumes, growth in ambulatory surgery, and expansion of integrated health systems. The South also has a large population of older adults, supporting recurring demand for surgical care, endoscopy, dialysis, long-term care, and infection-prevention infrastructure.

Texas is the largest state-level market in the region. Houston, Dallas-Fort Worth, Austin, and San Antonio contain major academic hospitals, children’s hospitals, cancer centers, cardiovascular facilities, and multisite health systems. Texas also has medical device, pharmaceutical, and laboratory operations that require industrial sterilization and contamination-control equipment.

The state’s rapid population growth is creating new hospitals, ambulatory surgery centers, freestanding emergency departments, and specialty clinics. These facilities require compact sterilizers, washer-disinfectors, environmental decontamination equipment, instrument tracking, and service support. Large distances between facilities also increase the importance of remote monitoring and regionally distributed field service.

Florida is a major infection-prevention equipment market because of its large older population, high procedural volumes, extensive long-term care sector, and broad network of hospitals and ambulatory centers. Demand is strong for endoscope reprocessing, surgical instrument sterilization, dental sterilization, dialysis infection control, room decontamination, and water-management systems.

Florida’s vulnerability to hurricanes also influences procurement. Hospitals require equipment resilience, backup utilities, emergency water planning, and rapid service recovery. Suppliers that can support continuity planning and maintain regional parts inventories have an advantage.

North Carolina is an important market for hospitals, pharmaceutical manufacturing, biotechnology, contract research, and medical device production. The Research Triangle supports demand for cleanroom decontamination, component washing, sterilization validation, and laboratory infection-control equipment. Charlotte, Raleigh-Durham, Winston-Salem, and other metropolitan areas are also expanding clinical capacity.

Georgia, Tennessee and Virginia have strong regional health systems and growing outpatient procedure markets. Atlanta, Nashville, Richmond, Norfolk and Northern Virginia are important commercial centers. Tennessee also has a concentration of hospital management companies and healthcare services organizations that can influence enterprise purchasing across multiple states.

Maryland benefits from advanced academic institutions, federal health agencies, biotechnology activity, and sophisticated hospital systems. South Carolina is expanding healthcare capacity in rapidly growing metropolitan and coastal markets. Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia and Oklahoma have meaningful infection-prevention demand but face greater rural access, capital-budget, and workforce constraints.

In these states, equipment that improves standardization and reduces labor requirements may generate strong value. Regional health systems can centralize sterile processing for smaller facilities, while mobile and outsourced services can support rural hospitals.

West

The West represented an estimated USD 1.62 billion in 2025 and is expected to reach approximately USD 3.70 billion by 2035, expanding at a regional CAGR of approximately 8.61%. The region includes California, Washington, Oregon, Arizona, Nevada, Colorado, Utah, New Mexico, Idaho, Montana, Wyoming, Alaska and Hawaii.

The West is expected to grow fastest because of healthcare technology adoption, environmental regulation, population growth in selected states, biotechnology concentration, and demand for sustainable sterilization alternatives. The region is also influential in digital health, robotics, automation, and environmentally responsible healthcare procurement.

California is the dominant state market. It has the largest population, major academic health systems, extensive ambulatory care infrastructure, advanced medical device manufacturing, biotechnology clusters, and a large pharmaceutical sector. Hospitals in California often adopt energy-efficient, water-efficient, and low-emission equipment earlier than other markets because of regulatory expectations and sustainability commitments.

California is particularly important for low-temperature sterilization, instrument tracking, cleanroom decontamination, ultraviolet disinfection, water management, and digital workflow technology. Its medical device industry also creates substantial demand for contract sterilization and alternative sterilization validation.

Washington and Oregon have sophisticated integrated delivery networks and strong adoption of connected healthcare technology. Health systems in Seattle, Portland, Spokane, and other population centers frequently emphasize standardization, data integration, and environmental performance. The region’s life-science and research institutions also support specialized sterilization demand.

Arizona and Nevada are high-growth markets because of population expansion, hospital construction, older adult migration, and increased surgical capacity. Phoenix, Tucson, Las Vegas and Reno are adding hospital beds, ambulatory facilities, dental practices, and specialty centers. Water scarcity increases interest in equipment that reduces rinse cycles and utility consumption.

Colorado and Utah combine population growth with advanced health systems and technology-oriented clinical environments. Denver, Salt Lake City and surrounding metropolitan areas are attractive markets for automated sterile processing, instrument tracking, and outpatient reprocessing equipment.

New Mexico, Idaho, Montana, Wyoming, Alaska and Hawaii are smaller markets but present distinct logistical requirements. Remote locations, rural hospitals, weather conditions, island supply chains, and limited specialist availability increase the value of reliable equipment, remote diagnostics, preventive maintenance, and extended consumable inventories.

Northeast

The Northeast accounted for an estimated USD 1.74 billion in 2025 and is projected to reach approximately USD 3.55 billion by 2035, representing a CAGR of approximately 7.39%. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Vermont, New Hampshire and Maine.

The Northeast has one of the country’s highest concentrations of academic medical centers, teaching hospitals, research institutions, pharmaceutical companies, and complex surgical programs. This supports premium demand for advanced sterile processing technology, low-temperature sterilization, automated endoscope reprocessing, digital traceability, and validated contamination-control systems.

New York is the largest market in the region. New York City contains major tertiary and quaternary hospitals with high surgical, transplant, oncology, cardiac, and endoscopic volumes. These institutions require large-scale sterile processing capacity and sophisticated instrument-management systems.

Health systems in upstate New York also operate broad networks of community and rural hospitals. Enterprise standardization across these networks creates opportunities for scalable equipment platforms and centralized service agreements.

Pennsylvania has a large hospital base, major academic systems, medical device operations, pharmaceutical manufacturing, and healthcare networks extending across urban and rural markets. Philadelphia and Pittsburgh are particularly important for high-acuity care and clinical research.

New Jersey is a major pharmaceutical, biotechnology, and medical device manufacturing center. Demand extends beyond hospital equipment to cleanroom decontamination, industrial sterilization, laboratory washing, and contamination-control validation.

Massachusetts has a smaller population than New York or Pennsylvania but exerts significant influence through its academic hospitals, biotechnology industry, research institutions, and early adoption of healthcare technology. Boston-area providers are important reference customers for connected sterile processing, advanced endoscope reprocessing, and infection-prevention analytics.

Connecticut, Rhode Island, Vermont, New Hampshire and Maine provide stable hospital and outpatient demand. Rural and aging populations in northern New England increase the importance of equipment reliability, regional service coverage, and scalable infection-prevention systems.

Growth in the Northeast will be moderated by slower population expansion and mature hospital infrastructure. However, the region will remain attractive because of high procedure complexity, strict quality expectations, significant pharmaceutical investment, and frequent replacement of premium installed equipment.

Midwest

The Midwest represented approximately USD 1.38 billion in 2025 and is forecast to reach approximately USD 2.78 billion by 2035, expanding at an estimated CAGR of 7.25%. The region includes Illinois, Ohio, Michigan, Indiana, Wisconsin, Minnesota, Iowa, Missouri, Kansas, Nebraska, North Dakota and South Dakota.

The Midwest combines a large hospital base with medical device manufacturing, pharmaceutical production, industrial sterilization, and established regional health systems. Demand is relatively stable and less dependent on rapid population growth than the South or West.

Illinois is the largest state market in the Midwest. Chicago contains major academic hospitals, integrated delivery networks, outpatient facilities, pharmaceutical operations, and medical device companies. Large hospital systems provide opportunities for enterprise equipment contracts and centralized sterile processing strategies.

Ohio has a strong healthcare infrastructure with major clinical centers in Cleveland, Columbus and Cincinnati. The state has significant surgical, cardiovascular, transplant, oncology, and research activity requiring advanced sterilization and reprocessing systems.

Michigan supports demand through major health systems, manufacturing expertise, and medical technology activity. Detroit, Ann Arbor, Grand Rapids and other urban markets contain high-volume hospitals and specialty centers.

Minnesota is strategically influential because of its medical device ecosystem and concentration of healthcare expertise. The state supports hospital infection-prevention demand as well as industrial sterilization, device validation, packaging, and contract manufacturing activity.

Indiana and Wisconsin have established hospital networks, pharmaceutical production, and medical device manufacturing. Missouri, Iowa, Kansas and Nebraska provide stable demand from community hospitals, academic centers, dental facilities, long-term care providers, and regional referral systems.

North Dakota and South Dakota are smaller markets characterized by rural geography and regionalized healthcare delivery. Hospitals in these states prioritize equipment durability, service accessibility, remote monitoring, and the ability to process a broad mix of instruments with limited staff.

Manufacturers generally succeed in the Midwest through long-term provider relationships, dependable service, clinical education, lifecycle value, and flexible contracting. The region is expected to remain an important replacement market for steam sterilizers, washer-disinfectors, monitoring products, and instrument-tracking platforms.

 

Key Market Players

The U.S. Infection Prevention Equipment Competitive Landscape is moderately consolidated in large capital-equipment categories but remains fragmented across environmental disinfection, monitoring, water treatment, endoscope reprocessing, sterilization assurance, and specialty accessories.

Large manufacturers compete through broad product portfolios, installed equipment bases, hospital contracting, nationwide service networks, regulatory expertise, and recurring consumables. Specialized companies compete through workflow differentiation, faster technology development, application-specific expertise, and lower-cost equipment.

Competition is increasingly based on lifecycle value. Hospitals assess equipment reliability, maintenance response, consumable cost, chamber utilization, device compatibility, utility requirements, staff training, software integration, and upgrade capability. Suppliers that cannot provide effective service and implementation support may struggle even when their equipment has strong technical performance.

Some of the key players operating in the U.S. Infection Prevention Equipment Market include STERIS Corporation, Getinge AB, Advanced Sterilization Products, Fortive Corporation, Solventum Corporation, Ecolab Inc., Sotera Health Company, Sterigenics, Nordion, Stryker Corporation, Belimed AG, Steelco S.p.A., MMM Group, Tuttnauer, Matachana Group, Olympus Corporation, Pentax Medical, FUJIFILM Healthcare Americas Corporation, Cantel Medical, Medivators, Ruhof Corporation, Xenex Disinfection Services, UVDI, Skytron, TIDI Products, Medline Industries, Cardinal Health, BD, Metrex Research and Tristel.

STERIS has one of the broadest positions across steam sterilization, low-temperature sterilization, washer-disinfectors, endoscope reprocessing, sterile processing consumables, instrument repair, and contract sterilization services. Getinge and Belimed are strong competitors in sterile processing equipment and hospital workflow infrastructure.

Advanced Sterilization Products has a significant position in low-temperature hydrogen peroxide sterilization. Solventum competes in sterilization assurance, biological and chemical monitoring, packaging, and infection-prevention products. Sotera Health, Sterigenics and Nordion are central to industrial sterilization and medical device supply chains.

Olympus, Pentax Medical, FUJIFILM Healthcare and Medivators influence the endoscope reprocessing ecosystem through scope compatibility, automated reprocessing, drying, storage, and service. Xenex, UVDI and other specialized companies compete in ultraviolet environmental disinfection.

Future market share will be shaped by the ability to develop alternative sterilization methods, secure device compatibility claims, support hospital cybersecurity requirements, maintain service uptime, and demonstrate measurable workflow improvements. Consolidation is likely to continue as diversified medtech companies seek broader infection-prevention portfolios and recurring service revenue.

 

Recent Developments

Recent developments in the U.S. Infection Prevention Equipment Market demonstrate a shift toward alternative sterilization, stronger environmental controls, digital process verification, and portfolio consolidation.

In January 2024, the FDA recognized vaporized hydrogen peroxide as an established Category A sterilization process for medical devices. This development strengthened the regulatory foundation for manufacturers seeking alternatives to ethylene oxide and supported investment in low-temperature sterilization equipment, validation, indicators, and compatible packaging.

In March 2024, the U.S. Environmental Protection Agency announced stricter emissions requirements for commercial ethylene oxide sterilization facilities. The finalized controls were designed to reduce emissions by more than 90%, while implementation provisions sought to protect the availability of sterilized medical devices.

The regulatory direction became less certain in 2026 when the EPA proposed reconsideration of the 2024 commercial sterilizer requirements. Regardless of the final policy outcome, the debate has made sterilization resilience a board-level issue for medical device manufacturers. Companies are evaluating redundant capacity, alternative methods, process optimization, emissions-control investments, and supplier diversification.

In April 2024, Solventum began operating as an independent healthcare company following its separation from 3M. The separation created a focused competitor with established sterilization assurance products across steam, ethylene oxide, and vaporized hydrogen peroxide processes.

In August 2024, Medline completed the acquisition of Ecolab’s global surgical solutions business. The transaction expanded Medline’s perioperative portfolio, including sterile drape and operating room products, and illustrated the broader consolidation occurring around infection prevention and surgical workflow.

National infection-prevention performance also improved. Acute care hospitals reported 2024 reductions of approximately 9% in central line-associated bloodstream infections, 10% in catheter-associated urinary tract infections, 2% in ventilator-associated events, 7% in hospital-onset MRSA bacteremia, and 11% in hospital-onset C. difficile infections compared with 2023. Surgical site infections following abdominal hysterectomy increased, showing that progress remains uneven.

The number of Medicare-certified ambulatory surgery centers reached approximately 6,436 in 2024. This expansion is increasing demand for compact sterilizers, endoscope reprocessors, ultrasonic cleaners, drying systems, tracking software, and equipment service models designed for outpatient economics.

Hospitals are also increasing investment in digital sterile processing. Instrument-tracking platforms, barcode systems, electronic load records, mobile workstations, and integrated maintenance analytics are becoming more important as health systems standardize workflows across multiple facilities.

The competitive environment is moving toward evidence-backed operational claims. Manufacturers are being asked to demonstrate reductions in water use, energy consumption, reprocessing time, equipment downtime, instrument loss, repair expense, and operating room delays. Infection-prevention equipment is increasingly evaluated as part of an integrated productivity and risk-management strategy.

 

Conclusion

The U.S. Infection Prevention Equipment Market Size & Share is positioned for sustained expansion from approximately USD 7.40 billion in 2025 to USD 15.84 billion by 2035, supported by a 7.90% CAGR during the forecast period 2026–2035.

The market’s long-term strength is grounded in the persistent burden of healthcare-associated infections, large surgical and endoscopic procedure volumes, expansion of ambulatory care, increasing complexity of reusable medical devices, and regulatory pressure surrounding sterilization quality and emissions.

Sterilization equipment will remain the largest product category, while low-temperature sterilization, digital traceability, automated endoscope reprocessing, environmental decontamination, and predictive equipment service will generate above-average growth. Hospitals and health systems will remain the dominant end users, but ambulatory surgery centers, specialty clinics, pharmaceutical manufacturers, and contract sterilization providers will increase their contribution.

Regional demand will be led by the South because of its population scale, hospital construction, older patient base, and outpatient expansion. The West will record the fastest growth because of its medical technology ecosystem, environmental priorities, and adoption of digitally connected equipment. The Northeast will remain a premium, evidence-intensive market, while the Midwest will provide stable demand from hospitals, medical device companies, pharmaceutical manufacturers, and contract sterilization operations.

For manufacturers and investors, the central commercial question is not simply how many sterilizers or disinfection systems U.S. facilities will purchase. The more important question is which platforms can protect procedural capacity, reduce process variation, strengthen compliance, improve staff productivity, and generate auditable proof that reusable devices and clinical environments are safe for patient care.

Companies that combine validated equipment, digital workflow integration, strong service infrastructure, recurring quality-control products, and measurable economic value will define the next decade of the U.S. infection prevention equipment industry.

 

TABLE OF CONTENT

1. U.S. Infection Prevention Equipment Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Infection Prevention Equipment Manufacturers
1.6.2. Sterilization Technology and Component Suppliers
1.6.3. Hospitals and Integrated Health Systems
1.6.4. Central Sterile Processing Departments
1.6.5. Ambulatory Surgery Centers and Specialty Clinics
1.6.6. Pharmaceutical and Medical Device Manufacturers
1.6.7. Contract Sterilization and Reprocessing Providers
1.6.8. Group Purchasing Organizations and Distributors
1.6.9. Infection Preventionists, Regulators, and Accreditation Bodies

What this section provides: This section defines the market boundary, study scope, methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. infection prevention equipment market is measured, segmented, and validated.

2. U.S. Infection Prevention Equipment Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.8. Key Hospital Procurement Priorities
2.9. Infection Prevention Technology Adoption Outlook

What this section provides: This section gives decision-makers a concise view of market size, growth direction, technology adoption, major demand pockets, competitive intensity, procurement priorities, and high-growth opportunities.

3. U.S. Infection Prevention Equipment Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Persistent Burden of Healthcare-Associated Infections
3.1.2. Expansion of Surgical and Endoscopic Procedure Volumes
3.1.3. Modernization of Central Sterile Processing Departments
3.1.4. Growth of Ambulatory Surgery Centers and Outpatient Procedures
3.1.5. Increasing Complexity of Reusable Medical Devices
3.1.6. Rising Demand for Automated Endoscope Reprocessing
3.1.7. Regulatory Transition Toward Alternative Sterilization Technologies
3.1.8. Hospital Focus on Quality Metrics and Infection-Related Cost Reduction
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Sterilization and Reprocessing Equipment
3.2.2. Extended Equipment Replacement and Validation Cycles
3.2.3. Shortage of Qualified Sterile Processing Personnel
3.2.4. Device Compatibility and Instructions-for-Use Complexity
3.2.5. Infrastructure and Space Constraints in Existing Facilities
3.2.6. Budget Pressure Across Community and Rural Hospitals
3.3. Opportunities and Their Impact Analysis
3.3.1. Low-Temperature Sterilization Adoption
3.3.2. Vaporized Hydrogen Peroxide Sterilization Expansion
3.3.3. Digital Instrument Tracking and Traceability
3.3.4. Connected Sterile Processing Departments
3.3.5. Automated Endoscope Drying and Storage Solutions
3.3.6. Ultraviolet and No-Touch Room Decontamination
3.3.7. Sustainable and Water-Efficient Equipment Platforms
3.3.8. Outsourced and Mobile Sterilization Services
3.3.9. Pharmaceutical and Medical Device Manufacturing Expansion
3.4. Challenges and Their Impact Analysis
3.4.1. Ethylene Oxide Regulatory and Emissions-Control Uncertainty
3.4.2. Sterilization Capacity and Medical Device Supply-Chain Risk
3.4.3. Reprocessing Workflow Standardization Across Multisite Health Systems
3.4.4. Equipment Downtime and Service-Coverage Requirements
3.4.5. Cybersecurity and Data Integration Risks
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Sterile Processing Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Infection Prevention Return-on-Investment Analysis
3.9. Equipment Lifecycle Cost and Replacement-Cycle Analysis

What this section provides: This section explains the clinical, regulatory, operational, environmental, and commercial forces shaping market demand, helping clients assess growth opportunities, adoption barriers, and execution risks.

4. U.S. Infection Prevention Equipment Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization and Connected Sterile Processing
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. EPA Sterilization Emissions and Environmental Compliance Landscape
4.9. CDC Infection Prevention Guidelines and Surveillance Framework
4.10. CMS Quality, Reimbursement, and Hospital-Acquired Condition Landscape
4.11. Accreditation and Sterile Processing Compliance Requirements
4.12. Import/Export Restrictions & Tariff Impact
4.13. Government Initiatives and Public Health Programs
4.14. Impact of Escalating Geopolitical Tensions
4.15. Medical Device Sterilization Supply-Chain Resilience Analysis
4.16. Hospital Value Analysis Committee Decision Framework
4.17. Sustainability and Utility Consumption Analysis
4.18. Equipment Service, Maintenance, and Uptime Requirements

What this section provides: This section gives clients a complete view of regulation, environmental compliance, reimbursement, pricing, supply chains, technology adoption, sustainability, and hospital procurement dynamics.

5. U.S. Infection Prevention Equipment Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Sterilization Equipment
5.1.2.1. Steam Sterilizers
5.1.2.2. Low-Temperature Sterilizers
5.1.2.3. Ethylene Oxide Sterilization Systems
5.1.2.4. Vaporized Hydrogen Peroxide Sterilizers
5.1.2.5. Dry-Heat Sterilizers
5.1.2.6. Radiation Sterilization Equipment
5.1.2.7. Other Sterilization Systems
5.1.3. Washer-Disinfectors and Cleaning Equipment
5.1.3.1. Single-Chamber Washer-Disinfectors
5.1.3.2. Multi-Chamber and Tunnel Washer-Disinfectors
5.1.3.3. Cart Washers
5.1.3.4. Ultrasonic Cleaning Systems
5.1.3.5. Automated Flushing and Irrigation Systems
5.1.3.6. Manual Cleaning Workstations
5.1.4. Endoscope Reprocessing Equipment
5.1.4.1. Automated Endoscope Reprocessors
5.1.4.2. Endoscope Leak Testers
5.1.4.3. Endoscope Drying Cabinets
5.1.4.4. Channel-Drying Systems
5.1.4.5. Endoscope Storage Systems
5.1.4.6. Endoscope Transport Systems
5.1.4.7. Borescope Inspection Systems
5.1.5. Environmental Disinfection and Room-Decontamination Equipment
5.1.5.1. Ultraviolet-C Disinfection Systems
5.1.5.2. Pulsed Ultraviolet Disinfection Systems
5.1.5.3. Vaporized Hydrogen Peroxide Room-Decontamination Systems
5.1.5.4. Electrostatic Disinfection Equipment
5.1.5.5. Aerosolized Disinfection Systems
5.1.5.6. Mobile and Autonomous Disinfection Platforms
5.1.6. Sterilization Monitoring and Traceability Products
5.1.6.1. Biological Indicators
5.1.6.2. Chemical Indicators
5.1.6.3. Process Challenge Devices
5.1.6.4. Indicator Incubators and Readers
5.1.6.5. Instrument-Tracking Systems
5.1.6.6. Load Documentation and Traceability Software
5.1.7. Sterilization Packaging and Accessories
5.1.7.1. Sterilization Wraps
5.1.7.2. Sterilization Pouches and Reels
5.1.7.3. Rigid Sterilization Containers
5.1.7.4. Labels and Identification Products
5.1.7.5. Equipment Detergents and Process Chemicals
5.1.7.6. Replacement Components and Accessories

What this section provides: This section identifies which infection prevention equipment categories are expected to generate the highest revenue contribution, recurring consumable demand, and strongest growth through 2035.

6. U.S. Infection Prevention Equipment Market – By Technology

6.1. Overview
6.1.1. Segment Share Analysis, By Technology, 2025 & 2035 (%)
6.1.2. Steam and Thermal Sterilization
6.1.2.1. Gravity Steam Sterilization
6.1.2.2. Pre-Vacuum Steam Sterilization
6.1.2.3. Immediate-Use Steam Sterilization
6.1.2.4. Dry-Heat Sterilization
6.1.3. Low-Temperature Chemical and Gas Sterilization
6.1.3.1. Vaporized Hydrogen Peroxide
6.1.3.2. Ethylene Oxide
6.1.3.3. Nitrogen Dioxide
6.1.3.4. Chlorine Dioxide
6.1.3.5. Ozone Sterilization
6.1.3.6. Vaporized Peracetic Acid
6.1.3.7. Other Low-Temperature Technologies
6.1.4. Automated Cleaning and High-Level Disinfection
6.1.4.1. Thermal Washer-Disinfection
6.1.4.2. Chemical High-Level Disinfection
6.1.4.3. Automated Endoscope Reprocessing
6.1.4.4. Ultrasonic Cleaning
6.1.4.5. Automated Chemical Dosing and Monitoring
6.1.5. Ultraviolet and No-Touch Decontamination
6.1.5.1. Continuous-Wave UV-C
6.1.5.2. Pulsed Xenon Ultraviolet
6.1.5.3. Upper-Room Ultraviolet Germicidal Irradiation
6.1.5.4. Whole-Room Vapor Decontamination
6.1.5.5. Autonomous No-Touch Disinfection
6.1.6. Digital, Sensor-Based and Connected Technologies
6.1.6.1. Barcode-Based Instrument Tracking
6.1.6.2. Radio-Frequency Identification Tracking
6.1.6.3. Automated Cycle Documentation
6.1.6.4. Water-Quality and Environmental Sensors
6.1.6.5. Computer Vision and Instrument Recognition
6.1.6.6. Remote Equipment Monitoring
6.1.6.7. Predictive Maintenance Analytics
6.1.6.8. AI-Assisted Sterile Processing Workflow Management

What this section provides: This section evaluates the sterilization, disinfection, automation, ultraviolet, tracking, sensor, and connected technologies reshaping infection prevention workflows.

7. U.S. Infection Prevention Equipment Market – By Application

7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
7.1.2. Surgical Instrument Reprocessing
7.1.2.1. General Surgery Instruments
7.1.2.2. Orthopedic Instruments
7.1.2.3. Robotic and Minimally Invasive Surgery Instruments
7.1.2.4. Cardiovascular and Neurosurgical Instruments
7.1.2.5. Ophthalmic and Microsurgical Instruments
7.1.2.6. Dental and Specialty Surgical Instruments
7.1.3. Endoscope Reprocessing
7.1.3.1. Gastrointestinal Endoscopes
7.1.3.2. Bronchoscopes
7.1.3.3. Urology Endoscopes
7.1.3.4. ENT Endoscopes
7.1.3.5. Surgical Endoscopes
7.1.3.6. Other Flexible and Semi-Critical Endoscopes
7.1.4. Environmental and Surface Decontamination
7.1.4.1. Patient Rooms
7.1.4.2. Operating Rooms
7.1.4.3. Intensive Care Units
7.1.4.4. Isolation Rooms
7.1.4.5. Emergency Departments
7.1.4.6. Laboratories and Cleanrooms
7.1.4.7. Ambulatory Procedure Rooms
7.1.5. Medical Device and Pharmaceutical Manufacturing
7.1.5.1. Implantable Medical Devices
7.1.5.2. Single-Use Medical Devices
7.1.5.3. Sterile Pharmaceutical Products
7.1.5.4. Biologics and Advanced Therapies
7.1.5.5. Packaging Components
7.1.5.6. Manufacturing Cleanrooms and Controlled Environments
7.1.6. Air, Water and Facility Infection Control
7.1.6.1. Air Filtration and Air Disinfection
7.1.6.2. Sterile Processing Water Treatment
7.1.6.3. Endoscope Reprocessing Water Management
7.1.6.4. Steam Generation and Boiler Water Treatment
7.1.6.5. Healthcare Plumbing and Waterborne Pathogen Control
7.1.6.6. Environmental Monitoring

What this section provides: This section helps clients understand demand by infection-prevention application and identify areas with high procedural volume, regulatory importance, recurring equipment use, and workflow complexity.

8. U.S. Infection Prevention Equipment Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Hospitals and Integrated Health Systems
8.1.2.1. Academic Medical Centers
8.1.2.2. Large Tertiary and Quaternary Hospitals
8.1.2.3. Community Hospitals
8.1.2.4. Critical Access and Rural Hospitals
8.1.2.5. Children’s Hospitals
8.1.2.6. Federal and Military Hospitals
8.1.3. Ambulatory Surgery Centers and Specialty Clinics
8.1.3.1. Multispecialty Ambulatory Surgery Centers
8.1.3.2. Gastroenterology Centers
8.1.3.3. Ophthalmology Centers
8.1.3.4. Orthopedic and Pain-Management Centers
8.1.3.5. Dental and Oral Surgery Facilities
8.1.3.6. Office-Based Procedure Centers
8.1.4. Pharmaceutical and Medical Device Manufacturers
8.1.4.1. Medical Device Manufacturing Facilities
8.1.4.2. Pharmaceutical Manufacturing Facilities
8.1.4.3. Biotechnology and Advanced Therapy Facilities
8.1.4.4. Contract Development and Manufacturing Organizations
8.1.4.5. Research and Quality-Control Laboratories
8.1.5. Long-Term Care, Dental and Other Outpatient Facilities
8.1.5.1. Skilled Nursing Facilities
8.1.5.2. Assisted Living and Long-Term Care Facilities
8.1.5.3. Dental Practices
8.1.5.4. Dialysis Centers
8.1.5.5. Physician Offices and Urgent Care Centers
8.1.5.6. Diagnostic and Research Laboratories
8.1.6. Contract Sterilization and Reprocessing Service Providers
8.1.6.1. Ethylene Oxide Sterilization Providers
8.1.6.2. Radiation Sterilization Providers
8.1.6.3. Low-Temperature Sterilization Providers
8.1.6.4. Off-Site Sterile Processing Providers
8.1.6.5. Mobile Sterilization and Reprocessing Providers
8.1.6.6. Instrument Repair and Reprocessing Service Companies

What this section provides: This section explains which healthcare, manufacturing, outpatient, long-term care, and service-provider customer groups are expected to drive equipment purchasing and recurring infection-prevention demand.

9. U.S. Infection Prevention Equipment Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Individual Facility Capital Procurement
9.1.2.2. Multisite Health System Procurement
9.1.2.3. Central Sterile Processing Modernization Projects
9.1.2.4. Hospital Construction and Renovation Contracts
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. Enterprise Equipment Standardization
9.1.3.2. Multiyear Equipment and Service Agreements
9.1.3.3. Consumable and Indicator Bundling
9.1.3.4. Software and Instrument-Tracking Agreements
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Contracts
9.1.4.2. Regional GPO Contracts
9.1.4.3. Aggregated Capital Equipment Purchasing
9.1.4.4. Consumable and Accessory Contracts
9.1.5. Distributor and Specialty Supplier Sales
9.1.5.1. National Medical-Surgical Distributors
9.1.5.2. Regional Equipment Distributors
9.1.5.3. Dental and Outpatient Specialty Distributors
9.1.5.4. Laboratory and Life-Science Distributors
9.1.6. Ambulatory, Dental and Office-Based Procurement
9.1.6.1. Direct Manufacturer Sales
9.1.6.2. Authorized Dealer Networks
9.1.6.3. Online and Catalog-Based Procurement
9.1.6.4. Leasing and Equipment Financing
9.1.7. Contract Sterilization and Outsourced Service Agreements
9.1.7.1. Per-Load and Per-Unit Sterilization Contracts
9.1.7.2. Long-Term Capacity Reservation Agreements
9.1.7.3. Managed Sterile Processing Contracts
9.1.7.4. Equipment-as-a-Service Models

What this section provides: This section explains how infection prevention equipment, consumables, software, and services are purchased through direct hospital contracts, IDNs, GPOs, distributors, outpatient channels, and outsourced sterilization agreements.

10. U.S. Infection Prevention Equipment Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Hospital, ASC and Sterile Processing Infrastructure Analysis
10.1.4. Regional Healthcare-Associated Infection Burden Analysis
10.1.5. Regional Medical Device and Pharmaceutical Manufacturing Analysis
10.1.6. Regional Regulatory, Sustainability and Procurement Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Infection Prevention Equipment Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Infection Prevention Equipment Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Infection Prevention Equipment Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Infection Prevention Equipment Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify hospital infrastructure hubs, medical device manufacturing clusters, sterile processing modernization opportunities, outpatient growth markets, and state-level commercial priorities.

11. U.S. Infection Prevention Equipment Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking by Product Portfolio
11.4. Competitive Benchmarking by Technology Platform
11.5. Competitive Benchmarking by U.S. Service and Distribution Coverage
11.6. Company Profiles

11.6.1. STERIS Corporation
11.6.2. Getinge AB
11.6.3. Advanced Sterilization Products
11.6.4. Solventum Corporation
11.6.5. Ecolab Inc.
11.6.6. Sotera Health Company
11.6.7. Sterigenics
11.6.8. Nordion
11.6.9. Stryker Corporation
11.6.10. Belimed AG
11.6.11. Steelco S.p.A.
11.6.12. MMM Group
11.6.13. Tuttnauer
11.6.14. Matachana Group
11.6.15. Olympus Corporation
11.6.16. PENTAX Medical
11.6.17. FUJIFILM Healthcare Americas Corporation
11.6.18. Medivators
11.6.19. Ruhof Corporation
11.6.20. Xenex Disinfection Services
11.6.21. UVDI
11.6.22. Skytron
11.6.23. Medline Industries
11.6.24. Cardinal Health
11.6.25. BD

Note: Each company profile will include company overview, infection prevention equipment portfolio, sterilization and reprocessing technologies, U.S. market strategy, financial positioning, regulatory updates, partnerships, service capabilities, acquisitions, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market share visibility, technology positioning, portfolio depth, service-network analysis, and strategic intelligence on major infection prevention equipment companies.

12. U.S. Infection Prevention Equipment Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Vaporized Hydrogen Peroxide Sterilization
12.2.2. Alternative Low-Temperature Sterilization Platforms
12.2.3. AI-Assisted Instrument Identification and Inspection
12.2.4. Connected Sterile Processing Departments
12.2.5. Automated Endoscope Reprocessing and Drying
12.2.6. Autonomous Ultraviolet Room Disinfection
12.2.7. Predictive Maintenance and Remote Equipment Monitoring
12.2.8. Water-Efficient and Sustainable Sterilization Systems
12.3. Emerging Business Trends
12.3.1. Equipment-as-a-Service Models
12.3.2. Managed Sterile Processing Services
12.3.3. Enterprise Equipment Standardization
12.3.4. Consumable and Service Bundling
12.3.5. Expansion of Contract Sterilization Capacity
12.3.6. Shift Toward Digitally Auditable Infection Prevention
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Technology Adoption Roadmap, 2026–2035
12.7. Long-Term Sterilization Capacity and Supply-Chain Outlook

What this section provides: This section prepares clients for future technology shifts, sterilization capacity changes, emerging business models, investment opportunities, and potential market-adoption scenarios through 2035.

13. U.S. Infection Prevention Equipment Market: Strategic Recommendations

13.1. Recommendations for Infection Prevention Equipment Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Central Sterile Processing Departments
13.4. Recommendations for Ambulatory Surgery Centers and Specialty Clinics
13.5. Recommendations for Pharmaceutical and Medical Device Manufacturers
13.6. Recommendations for Contract Sterilization Providers
13.7. Recommendations for Investors and Private Equity Firms
13.8. Recommendations for Distributors and Channel Partners
13.9. Recommendations for New Entrants and Startups
13.10. Go-to-Market Strategy Considerations
13.11. Product Positioning and Portfolio Expansion Guidance
13.12. U.S. Service Network and Aftermarket Strategy
13.13. Regulatory and Environmental Risk-Mitigation Strategy
13.14. Digital Integration and Cybersecurity Strategy
13.15. Hospital Value Demonstration and ROI Strategy

What this section provides: This section converts market intelligence into actionable recommendations for product development, capital procurement, channel expansion, service strategy, investment decisions, regulatory planning, and competitive differentiation.

14. U.S. Infection Prevention Equipment Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Regulatory and Clinical Information Disclaimer
14.7. Market Estimation and Assumption Disclaimer

What this section provides: This section clarifies the report’s scope limitations, legal boundaries, data-use conditions, regulatory considerations, and market-forecasting assumptions.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Infection Prevention Equipment Market: Market Definition and Scope
TABLE 3: U.S. Infection Prevention Equipment Market: Research Methodology Framework
TABLE 4: U.S. Infection Prevention Equipment Market: Key Assumptions
TABLE 5: U.S. Infection Prevention Equipment Market: Market Ecosystem Overview
TABLE 6: U.S. Infection Prevention Equipment Market: Stakeholder Analysis
TABLE 7: U.S. Infection Prevention Equipment Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Infection Prevention Equipment Market: Analyst Viewpoint Summary
TABLE 9: U.S. Infection Prevention Equipment Market: Market Attractiveness Index
TABLE 10: U.S. Infection Prevention Equipment Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Infection Prevention Equipment Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Infection Prevention Equipment Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Infection Prevention Equipment Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 14: U.S. Infection Prevention Equipment Market: High-Growth Opportunity Areas
TABLE 15: U.S. Infection Prevention Equipment Market: Drivers; Impact Analysis
TABLE 16: U.S. Infection Prevention Equipment Market: Restraints; Impact Analysis
TABLE 17: U.S. Infection Prevention Equipment Market: Opportunities; Impact Analysis
TABLE 18: U.S. Infection Prevention Equipment Market: Challenges; Impact Analysis
TABLE 19: U.S. Infection Prevention Equipment Market: Patent & Innovation Analysis, 2021–2025
TABLE 20: U.S. Infection Prevention Equipment Market: Sterile Processing Workflow Economics Matrix
TABLE 21: U.S. Infection Prevention Equipment Market: Hospital Capital Procurement Behavior Matrix
TABLE 22: U.S. Infection Prevention Equipment Market: Infection Prevention ROI Analysis
TABLE 23: U.S. Infection Prevention Equipment Market: Equipment Lifecycle and Replacement-Cycle Analysis
TABLE 24: U.S. Infection Prevention Equipment Market: PESTEL Analysis
TABLE 25: U.S. Infection Prevention Equipment Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Infection Prevention Equipment Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 27: U.S. Infection Prevention Equipment Market: Value Chain Analysis
TABLE 28: U.S. Infection Prevention Equipment Market: Supply Chain Analysis
TABLE 29: U.S. Infection Prevention Equipment Market: Digitalization and Connected Sterile Processing Impact
TABLE 30: U.S. Infection Prevention Equipment Market: Application & Innovation Landscape
TABLE 31: U.S. Infection Prevention Equipment Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. Infection Prevention Equipment Market: EPA Sterilization Emissions and Environmental Compliance Landscape
TABLE 33: U.S. Infection Prevention Equipment Market: CDC Infection Prevention Guidelines and Surveillance Framework
TABLE 34: U.S. Infection Prevention Equipment Market: CMS Quality and Hospital-Acquired Condition Landscape
TABLE 35: U.S. Infection Prevention Equipment Market: Accreditation and Sterile Processing Compliance Requirements
TABLE 36: U.S. Infection Prevention Equipment Market: Import/Export Restrictions & Tariff Impact
TABLE 37: U.S. Infection Prevention Equipment Market: Government Initiatives and Public Health Programs
TABLE 38: U.S. Infection Prevention Equipment Market: Impact of Escalating Geopolitical Tensions
TABLE 39: U.S. Infection Prevention Equipment Market: Medical Device Sterilization Supply-Chain Resilience
TABLE 40: U.S. Infection Prevention Equipment Market: Hospital Value Analysis Committee Decision Framework
TABLE 41: U.S. Infection Prevention Equipment Market: Sustainability and Utility Consumption Analysis
TABLE 42: U.S. Infection Prevention Equipment Market: Equipment Service, Maintenance and Uptime Requirements
TABLE 43: U.S. Infection Prevention Equipment Market: Product Type Snapshot, 2025
TABLE 44: Segment Dashboard; Definition and Scope, by Product Type
TABLE 45: U.S. Infection Prevention Equipment Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 46: U.S. Infection Prevention Equipment Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 47: Sterilization Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: Washer-Disinfectors and Cleaning Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: Endoscope Reprocessing Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: Environmental Disinfection and Room-Decontamination Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: Sterilization Monitoring and Traceability Products Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: Sterilization Packaging and Accessories Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Infection Prevention Equipment Market: Technology Snapshot, 2025
TABLE 54: Segment Dashboard; Definition and Scope, by Technology
TABLE 55: U.S. Infection Prevention Equipment Market, by Technology, 2021–2035 (US$ Billion)
TABLE 56: U.S. Infection Prevention Equipment Market: Segment Share Analysis, by Technology, 2025 & 2035 (%)
TABLE 57: Steam and Thermal Sterilization Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: Low-Temperature Chemical and Gas Sterilization Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: Automated Cleaning and High-Level Disinfection Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: Ultraviolet and No-Touch Decontamination Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: Digital, Sensor-Based and Connected Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Infection Prevention Equipment Market: Application Snapshot, 2025
TABLE 63: Segment Dashboard; Definition and Scope, by Application
TABLE 64: U.S. Infection Prevention Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 65: U.S. Infection Prevention Equipment Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 66: Surgical Instrument Reprocessing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: Endoscope Reprocessing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: Environmental and Surface Decontamination Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: Medical Device and Pharmaceutical Manufacturing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: Air, Water and Facility Infection Control Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Infection Prevention Equipment Market: End User Snapshot, 2025
TABLE 72: Segment Dashboard; Definition and Scope, by End User
TABLE 73: U.S. Infection Prevention Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 74: U.S. Infection Prevention Equipment Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 75: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: Ambulatory Surgery Centers and Specialty Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: Pharmaceutical and Medical Device Manufacturers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: Long-Term Care, Dental and Other Outpatient Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: Contract Sterilization and Reprocessing Service Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Infection Prevention Equipment Market: Procurement Channel Snapshot, 2025
TABLE 81: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 82: U.S. Infection Prevention Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 83: U.S. Infection Prevention Equipment Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 84: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: Ambulatory, Dental and Office-Based Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 89: Contract Sterilization and Outsourced Service Agreements Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 90: U.S. Infection Prevention Equipment Market: Regional Snapshot, 2025
TABLE 91: Segment Dashboard; Definition and Scope, by Region
TABLE 92: U.S. Infection Prevention Equipment Market, by Region, 2021–2035 (US$ Billion)
TABLE 93: U.S. Infection Prevention Equipment Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 94: U.S. Infection Prevention Equipment Market: Regional Hospital, ASC and Sterile Processing Infrastructure
TABLE 95: U.S. Infection Prevention Equipment Market: Regional Healthcare-Associated Infection Burden
TABLE 96: U.S. Infection Prevention Equipment Market: Regional Medical Device and Pharmaceutical Manufacturing Analysis
TABLE 97: West Region U.S. Infection Prevention Equipment Market: Regional Overview and Trends
TABLE 98: West Region U.S. Infection Prevention Equipment Market: Key Manufacturers and Procurement Ecosystem
TABLE 99: West Region U.S. Infection Prevention Equipment Market, by State, 2021–2035 (US$ Billion)
TABLE 100: West Region U.S. Infection Prevention Equipment Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 101: West Region U.S. Infection Prevention Equipment Market, by Technology, 2021–2035 (US$ Billion)
TABLE 102: West Region U.S. Infection Prevention Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 103: West Region U.S. Infection Prevention Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 104: West Region U.S. Infection Prevention Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 105: California Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 106: Washington Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 107: Arizona Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 108: Colorado Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Oregon Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Utah Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Nevada Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: New Mexico Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Idaho Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Montana Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Wyoming Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Alaska Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Hawaii Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Northeast Region U.S. Infection Prevention Equipment Market: Regional Overview and Trends
TABLE 119: Northeast Region U.S. Infection Prevention Equipment Market: Key Manufacturers and Procurement Ecosystem
TABLE 120: Northeast Region U.S. Infection Prevention Equipment Market, by State, 2021–2035 (US$ Billion)
TABLE 121: Northeast Region U.S. Infection Prevention Equipment Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 122: Northeast Region U.S. Infection Prevention Equipment Market, by Technology, 2021–2035 (US$ Billion)
TABLE 123: Northeast Region U.S. Infection Prevention Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 124: Northeast Region U.S. Infection Prevention Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 125: Northeast Region U.S. Infection Prevention Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 126: New York Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Massachusetts Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: New Jersey Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Pennsylvania Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Connecticut Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Maine Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Vermont Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: New Hampshire Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: Rhode Island Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Delaware Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: South Region U.S. Infection Prevention Equipment Market: Regional Overview and Trends
TABLE 137: South Region U.S. Infection Prevention Equipment Market: Key Manufacturers and Procurement Ecosystem
TABLE 138: South Region U.S. Infection Prevention Equipment Market, by State, 2021–2035 (US$ Billion)
TABLE 139: South Region U.S. Infection Prevention Equipment Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 140: South Region U.S. Infection Prevention Equipment Market, by Technology, 2021–2035 (US$ Billion)
TABLE 141: South Region U.S. Infection Prevention Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 142: South Region U.S. Infection Prevention Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 143: South Region U.S. Infection Prevention Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 144: Texas Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Florida Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Georgia Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: North Carolina Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Tennessee Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: South Carolina Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Alabama Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Mississippi Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Louisiana Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Arkansas Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Kentucky Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: Oklahoma Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: Virginia Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: Maryland Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 158: West Virginia Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 159: Midwest Region U.S. Infection Prevention Equipment Market: Regional Overview and Trends
TABLE 160: Midwest Region U.S. Infection Prevention Equipment Market: Key Manufacturers and Procurement Ecosystem
TABLE 161: Midwest Region U.S. Infection Prevention Equipment Market, by State, 2021–2035 (US$ Billion)
TABLE 162: Midwest Region U.S. Infection Prevention Equipment Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 163: Midwest Region U.S. Infection Prevention Equipment Market, by Technology, 2021–2035 (US$ Billion)
TABLE 164: Midwest Region U.S. Infection Prevention Equipment Market, by Application, 2021–2035 (US$ Billion)
TABLE 165: Midwest Region U.S. Infection Prevention Equipment Market, by End User, 2021–2035 (US$ Billion)
TABLE 166: Midwest Region U.S. Infection Prevention Equipment Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 167: Illinois Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 168: Ohio Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 169: Michigan Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 170: Minnesota Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 171: Indiana Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 172: Wisconsin Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 173: Missouri Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 174: Iowa Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 175: Kansas Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 176: Nebraska Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 177: North Dakota Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 178: South Dakota Infection Prevention Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 179: U.S. Infection Prevention Equipment Market: Competitive Landscape Snapshot, 2025
TABLE 180: U.S. Infection Prevention Equipment Market: Key Company Market Share Analysis, 2025
TABLE 181: U.S. Infection Prevention Equipment Market: Company Positioning Matrix
TABLE 182: U.S. Infection Prevention Equipment Market: Product Portfolio Benchmarking of Key Players
TABLE 183: U.S. Infection Prevention Equipment Market: Technology Platform Benchmarking of Key Players
TABLE 184: U.S. Infection Prevention Equipment Market: U.S. Service and Distribution Coverage Benchmarking
TABLE 185: U.S. Infection Prevention Equipment Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 186: STERIS Corporation: Company Profile
TABLE 187: Getinge AB: Company Profile
TABLE 188: Advanced Sterilization Products: Company Profile
TABLE 189: Solventum Corporation: Company Profile
TABLE 190: Ecolab Inc.: Company Profile
TABLE 191: Sotera Health Company: Company Profile
TABLE 192: Sterigenics: Company Profile
TABLE 193: Nordion: Company Profile
TABLE 194: Stryker Corporation: Company Profile
TABLE 195: Belimed AG: Company Profile
TABLE 196: Steelco S.p.A.: Company Profile
TABLE 197: MMM Group: Company Profile
TABLE 198: Tuttnauer: Company Profile
TABLE 199: Matachana Group: Company Profile
TABLE 200: Olympus Corporation: Company Profile
TABLE 201: PENTAX Medical: Company Profile
TABLE 202: FUJIFILM Healthcare Americas Corporation: Company Profile
TABLE 203: Medivators: Company Profile
TABLE 204: Ruhof Corporation: Company Profile
TABLE 205: Xenex Disinfection Services: Company Profile
TABLE 206: UVDI: Company Profile
TABLE 207: Skytron: Company Profile
TABLE 208: Medline Industries: Company Profile
TABLE 209: Cardinal Health: Company Profile
TABLE 210: BD: Company Profile
TABLE 211: U.S. Infection Prevention Equipment Market: Future Market Scenario Analysis, 2026–2035
TABLE 212: U.S. Infection Prevention Equipment Market: Disruptive Technologies Impact Matrix
TABLE 213: U.S. Infection Prevention Equipment Market: Emerging Business Trends
TABLE 214: U.S. Infection Prevention Equipment Market: Business Opportunities for Startups and Existing Players
TABLE 215: U.S. Infection Prevention Equipment Market: Investment Prioritization Matrix
TABLE 216: U.S. Infection Prevention Equipment Market: Technology Adoption Roadmap, 2026–2035
TABLE 217: U.S. Infection Prevention Equipment Market: Long-Term Sterilization Capacity and Supply-Chain Outlook
TABLE 218: U.S. Infection Prevention Equipment Market: Strategic Recommendations for Equipment Manufacturers
TABLE 219: U.S. Infection Prevention Equipment Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 220: U.S. Infection Prevention Equipment Market: Strategic Recommendations for Central Sterile Processing Departments
TABLE 221: U.S. Infection Prevention Equipment Market: Strategic Recommendations for Ambulatory Surgery Centers and Specialty Clinics
TABLE 222: U.S. Infection Prevention Equipment Market: Strategic Recommendations for Pharmaceutical and Medical Device Manufacturers
TABLE 223: U.S. Infection Prevention Equipment Market: Strategic Recommendations for Contract Sterilization Providers
TABLE 224: U.S. Infection Prevention Equipment Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 225: U.S. Infection Prevention Equipment Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 226: U.S. Infection Prevention Equipment Market: Strategic Recommendations for New Entrants and Startups
TABLE 227: U.S. Infection Prevention Equipment Market: Go-to-Market Strategy Considerations
TABLE 228: U.S. Infection Prevention Equipment Market: Product Positioning and Portfolio Expansion Guidance
TABLE 229: U.S. Infection Prevention Equipment Market: U.S. Service Network and Aftermarket Strategy
TABLE 230: U.S. Infection Prevention Equipment Market: Regulatory and Environmental Risk-Mitigation Strategy
TABLE 231: U.S. Infection Prevention Equipment Market: Digital Integration and Cybersecurity Strategy
TABLE 232: U.S. Infection Prevention Equipment Market: Hospital Value Demonstration and ROI Strategy
TABLE 233: U.S. Infection Prevention Equipment Market: Scope Limitation
TABLE 234: U.S. Infection Prevention Equipment Market: Data Use Limitation
TABLE 235: U.S. Infection Prevention Equipment Market: Forecasting Limitation
TABLE 236: U.S. Infection Prevention Equipment Market: Legal Disclaimer
TABLE 237: U.S. Infection Prevention Equipment Market: Third-Party Data Disclaimer
TABLE 238: U.S. Infection Prevention Equipment Market: Regulatory and Clinical Information Disclaimer
TABLE 239: U.S. Infection Prevention Equipment Market: Market Estimation and Assumption Disclaimer

List of Figures

FIGURE 1: U.S. Infection Prevention Equipment Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Framework
FIGURE 4: Value Chain Analysis
FIGURE 5: Supply Chain Analysis
FIGURE 6: PESTEL Analysis
FIGURE 7: Porter’s Five Forces Analysis
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Sterile Processing Workflow Economics Framework
FIGURE 12: Hospital Capital Procurement Decision Framework
FIGURE 13: Infection Prevention ROI Framework
FIGURE 14: U.S. Infection Prevention Equipment Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 15: U.S. Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 16: U.S. Infection Prevention Equipment Market Year-wise Growth Curve, 2021–2035
FIGURE 17: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 18: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Sterilization Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Washer-Disinfectors and Cleaning Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Endoscope Reprocessing Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Environmental Disinfection and Room-Decontamination Equipment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Sterilization Monitoring and Traceability Products Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Sterilization Packaging and Accessories Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Technology Segment Market Share Analysis, 2025 & 2035
FIGURE 26: Technology Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Steam and Thermal Sterilization Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Low-Temperature Chemical and Gas Sterilization Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Automated Cleaning and High-Level Disinfection Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Ultraviolet and No-Touch Decontamination Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Digital, Sensor-Based and Connected Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 33: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Surgical Instrument Reprocessing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Endoscope Reprocessing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Environmental and Surface Decontamination Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Medical Device and Pharmaceutical Manufacturing Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Air, Water and Facility Infection Control Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 40: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Ambulatory Surgery Centers and Specialty Clinics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Pharmaceutical and Medical Device Manufacturers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Long-Term Care, Dental and Other Outpatient Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Contract Sterilization and Reprocessing Service Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 47: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Ambulatory, Dental and Office-Based Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Contract Sterilization and Outsourced Service Agreements Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 55: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: West Region U.S. Infection Prevention Equipment Market Share and Leading Players, 2025
FIGURE 57: West Region Market Share Analysis by State, 2025
FIGURE 58: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: California Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Washington Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Arizona Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Colorado Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Oregon Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Utah Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Nevada Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: New Mexico Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Idaho Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Montana Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Wyoming Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Alaska Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Hawaii Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Northeast Region U.S. Infection Prevention Equipment Market Share and Leading Players, 2025
FIGURE 73: Northeast Region Market Share Analysis by State, 2025
FIGURE 74: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: New York Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: Massachusetts Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New Jersey Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Pennsylvania Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Connecticut Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Maine Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Vermont Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: New Hampshire Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Rhode Island Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Delaware Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: South Region U.S. Infection Prevention Equipment Market Share and Leading Players, 2025
FIGURE 86: South Region Market Share Analysis by State, 2025
FIGURE 87: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Texas Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Florida Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Georgia Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: North Carolina Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Tennessee Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: South Carolina Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Alabama Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Mississippi Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Louisiana Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Arkansas Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Kentucky Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Oklahoma Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Virginia Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Maryland Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: West Virginia Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Midwest Region U.S. Infection Prevention Equipment Market Share and Leading Players, 2025
FIGURE 104: Midwest Region Market Share Analysis by State, 2025
FIGURE 105: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Illinois Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Ohio Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Michigan Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Minnesota Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Indiana Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Wisconsin Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Missouri Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Iowa Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Kansas Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Nebraska Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: North Dakota Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: South Dakota Infection Prevention Equipment Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 119: Company Positioning Matrix
FIGURE 120: Key Player Product Portfolio Benchmarking
FIGURE 121: Technology Platform Benchmarking of Key Players
FIGURE 122: U.S. Service and Distribution Coverage Benchmarking
FIGURE 123: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 124: Infection Prevention Equipment Innovation Roadmap
FIGURE 125: Alternative Low-Temperature Sterilization Adoption Roadmap
FIGURE 126: Connected Sterile Processing Technology Roadmap
FIGURE 127: Automated Endoscope Reprocessing Opportunity Map
FIGURE 128: Ultraviolet and No-Touch Disinfection Adoption Roadmap
FIGURE 129: Future Market Scenario Analysis, 2026–2035
FIGURE 130: Disruptive Technologies Impact Matrix
FIGURE 131: Emerging Business Trends Matrix
FIGURE 132: Investment Prioritization Matrix
FIGURE 133: Strategic Growth Roadmap for U.S. Infection Prevention Equipment Companies
FIGURE 134: Go-to-Market Strategy Framework
FIGURE 135: Product Positioning and Portfolio Expansion Framework
FIGURE 136: Hospital Value Demonstration and ROI Framework
FIGURE 137: Report Scope and Disclaimer Framework